Ignite Creation Date:
2024-05-06 @ 1:18 PM
Last Modification Date:
2024-10-26 @ 1:11 PM
Study NCT ID:
NCT03980483
Status:
COMPLETED
Last Update Posted:
2024-03-27
First Post:
2019-05-15
Brief Title:
Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline